Table 3. Characteristics of 41 patients with disseminated testicular cancer and treated with cisplatin containing combination chemotherapy.
| Median (range) | Number (%) | |
|---|---|---|
| Number of patients | 41 | |
| Age at start of treatment, years | 31 (18–46) | |
| Diagnosis | ||
| Non-seminoma | 35 (85.4) | |
| Seminoma | 6 (14.6) | |
| IGCCCG prognosis group | ||
| Good | 33 (80.5) | |
| Intermediate | 7 (17.1) | |
| Poor | 1 (2.4) | |
| Tumor Stage | ||
| II | 30 (73.2) | |
| III | 4 (9.8) | |
| IV | 7 (17.1) | |
| Treatment regimen | ||
| 3 cycles BEP | 29 (70.7) | |
| 4 cycles BEP | 11 (26.8) | |
| 4 cycles EP | 1 (2.4) |
Abbreviations: International Germ Cell Cancer Collaborative Group (IGCCCG); bleomycin etoposide cisplatin chemotherapy (BEP).